Pyrophosphoric acid

DB04160ApprovedInvestigationalSmall molecule

Pyrophosphoric acid is an ingredient of a radiopharmaceutical used to visualize bone abnormalities and cardiovascular abnormalities and also used as an ingredient in some products to prevent iron deficiency anemia. An ingredient used in radioactive medications that help to see body tissues such as the heart and bones during medical imaging tests and is used as an ingredient in some products to prevent iron deficiency.

Chemical structure of Pyrophosphoric acid
Formula / weight
H4O7P2 · 177.9751 g/mol (avg)
First approval
United States, 1976
Also known as
Diphosphoric acid

Resolves to

Compound
UNII4E862E7GRQCAS2466-09-3ChEMBLCHEMBL1160571ChEBI29888PubChem21961011KEGGC00013
Clinical / RWD
RxNorm1546425
Structure
InChIKeyXPPKVPWEQAFLFU-UHFFFAOYSA-NSMILESOP(O)(=O)OP(O)(O)=O
Targets
P14324FDPSP22939ispA

What you can answer from here — as of September 24, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
63Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
39Marketed productsAcross 3 countries and 20 labellers
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pyrophosphoric acid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In